Review





Similar Products

human her2 female breast cancer cell lines bt474 ts  (ATCC)
99
ATCC human her2 female breast cancer cell lines bt474 ts
Human Her2 Female Breast Cancer Cell Lines Bt474 Ts, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/human her2 female breast cancer cell lines bt474 ts/product/ATCC
Average 99 stars, based on 1 article reviews
human her2 female breast cancer cell lines bt474 ts - by Bioz Stars, 2026-05
99/100 stars
  Buy from Supplier
trastuzumab deruxtecan her2  (Daiichi Sankyo)
86
Daiichi Sankyo trastuzumab deruxtecan her2
Trastuzumab Deruxtecan Her2, supplied by Daiichi Sankyo, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/trastuzumab deruxtecan her2/product/Daiichi Sankyo
Average 86 stars, based on 1 article reviews
trastuzumab deruxtecan her2 - by Bioz Stars, 2026-05
86/100 stars
  Buy from Supplier
her2  (Affibody)
86
Affibody her2
Her2, supplied by Affibody, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/her2/product/Affibody
Average 86 stars, based on 1 article reviews
her2 - by Bioz Stars, 2026-05
86/100 stars
  Buy from Supplier
her2  (Galectin Therapeutics)
86
Galectin Therapeutics her2
Immunohistochemical (IHC) staining in control and marked groups. Lung cance ( A ) The immunohistochemical scores of the control group were TTF-1 (3+, 90%), Napsin A (3+, 80%), p53 (2+, 50%), Ki-67 (2+,70%), and PD-L1 (TPS < 1%). The immunohistochemical scores of the nano-TiO₂ group were TTF-1 (2+, 60%), Napsin A (3+, 90%), p53 (2+, 45%), Ki-67 (85%), and PD-L1 (TPS < 1%).TPS, tumor proportion score; Thyroid cancer ( B ) The immunohistochemical scores of the control group were Galectin-3 (3+, 90%), TPO (1+, 3%), CD56 (0), and BRAF V600E (3+, 80%). The immunohistochemical scores of the nano-TiO 2 group were Galectin-3 (2+, 70%), TPO (1+, 5%), CD56 (2+, 10%), and BRAF V600E (3+, 90%); Breast cancer ( C ) The immunohistochemical scores of the control group were ER (2+, 30%), PR (3+, 30%), and <t>HER2</t> (1+). The immunohistochemical scores of the DB group were ER (2+, 80%), PR (3+, 80%), and HER2 (1+) (×200)
Her2, supplied by Galectin Therapeutics, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/her2/product/Galectin Therapeutics
Average 86 stars, based on 1 article reviews
her2 - by Bioz Stars, 2026-05
86/100 stars
  Buy from Supplier
her2 trastuzumab  (Procell Inc)
86
Procell Inc her2 trastuzumab
Immunohistochemical (IHC) staining in control and marked groups. Lung cance ( A ) The immunohistochemical scores of the control group were TTF-1 (3+, 90%), Napsin A (3+, 80%), p53 (2+, 50%), Ki-67 (2+,70%), and PD-L1 (TPS < 1%). The immunohistochemical scores of the nano-TiO₂ group were TTF-1 (2+, 60%), Napsin A (3+, 90%), p53 (2+, 45%), Ki-67 (85%), and PD-L1 (TPS < 1%).TPS, tumor proportion score; Thyroid cancer ( B ) The immunohistochemical scores of the control group were Galectin-3 (3+, 90%), TPO (1+, 3%), CD56 (0), and BRAF V600E (3+, 80%). The immunohistochemical scores of the nano-TiO 2 group were Galectin-3 (2+, 70%), TPO (1+, 5%), CD56 (2+, 10%), and BRAF V600E (3+, 90%); Breast cancer ( C ) The immunohistochemical scores of the control group were ER (2+, 30%), PR (3+, 30%), and <t>HER2</t> (1+). The immunohistochemical scores of the DB group were ER (2+, 80%), PR (3+, 80%), and HER2 (1+) (×200)
Her2 Trastuzumab, supplied by Procell Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/her2 trastuzumab/product/Procell Inc
Average 86 stars, based on 1 article reviews
her2 trastuzumab - by Bioz Stars, 2026-05
86/100 stars
  Buy from Supplier
her2 recognition  (Affibody)
86
Affibody her2 recognition
Immunohistochemical (IHC) staining in control and marked groups. Lung cance ( A ) The immunohistochemical scores of the control group were TTF-1 (3+, 90%), Napsin A (3+, 80%), p53 (2+, 50%), Ki-67 (2+,70%), and PD-L1 (TPS < 1%). The immunohistochemical scores of the nano-TiO₂ group were TTF-1 (2+, 60%), Napsin A (3+, 90%), p53 (2+, 45%), Ki-67 (85%), and PD-L1 (TPS < 1%).TPS, tumor proportion score; Thyroid cancer ( B ) The immunohistochemical scores of the control group were Galectin-3 (3+, 90%), TPO (1+, 3%), CD56 (0), and BRAF V600E (3+, 80%). The immunohistochemical scores of the nano-TiO 2 group were Galectin-3 (2+, 70%), TPO (1+, 5%), CD56 (2+, 10%), and BRAF V600E (3+, 90%); Breast cancer ( C ) The immunohistochemical scores of the control group were ER (2+, 30%), PR (3+, 30%), and <t>HER2</t> (1+). The immunohistochemical scores of the DB group were ER (2+, 80%), PR (3+, 80%), and HER2 (1+) (×200)
Her2 Recognition, supplied by Affibody, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/her2 recognition/product/Affibody
Average 86 stars, based on 1 article reviews
her2 recognition - by Bioz Stars, 2026-05
86/100 stars
  Buy from Supplier
her2 targeting affibody drug conjugates  (Affibody)
86
Affibody her2 targeting affibody drug conjugates
Immunohistochemical (IHC) staining in control and marked groups. Lung cance ( A ) The immunohistochemical scores of the control group were TTF-1 (3+, 90%), Napsin A (3+, 80%), p53 (2+, 50%), Ki-67 (2+,70%), and PD-L1 (TPS < 1%). The immunohistochemical scores of the nano-TiO₂ group were TTF-1 (2+, 60%), Napsin A (3+, 90%), p53 (2+, 45%), Ki-67 (85%), and PD-L1 (TPS < 1%).TPS, tumor proportion score; Thyroid cancer ( B ) The immunohistochemical scores of the control group were Galectin-3 (3+, 90%), TPO (1+, 3%), CD56 (0), and BRAF V600E (3+, 80%). The immunohistochemical scores of the nano-TiO 2 group were Galectin-3 (2+, 70%), TPO (1+, 5%), CD56 (2+, 10%), and BRAF V600E (3+, 90%); Breast cancer ( C ) The immunohistochemical scores of the control group were ER (2+, 30%), PR (3+, 30%), and <t>HER2</t> (1+). The immunohistochemical scores of the DB group were ER (2+, 80%), PR (3+, 80%), and HER2 (1+) (×200)
Her2 Targeting Affibody Drug Conjugates, supplied by Affibody, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/her2 targeting affibody drug conjugates/product/Affibody
Average 86 stars, based on 1 article reviews
her2 targeting affibody drug conjugates - by Bioz Stars, 2026-05
86/100 stars
  Buy from Supplier
her2 positive metastatic breast cancer cells  (ATCC)
95
ATCC her2 positive metastatic breast cancer cells
Immunohistochemical (IHC) staining in control and marked groups. Lung cance ( A ) The immunohistochemical scores of the control group were TTF-1 (3+, 90%), Napsin A (3+, 80%), p53 (2+, 50%), Ki-67 (2+,70%), and PD-L1 (TPS < 1%). The immunohistochemical scores of the nano-TiO₂ group were TTF-1 (2+, 60%), Napsin A (3+, 90%), p53 (2+, 45%), Ki-67 (85%), and PD-L1 (TPS < 1%).TPS, tumor proportion score; Thyroid cancer ( B ) The immunohistochemical scores of the control group were Galectin-3 (3+, 90%), TPO (1+, 3%), CD56 (0), and BRAF V600E (3+, 80%). The immunohistochemical scores of the nano-TiO 2 group were Galectin-3 (2+, 70%), TPO (1+, 5%), CD56 (2+, 10%), and BRAF V600E (3+, 90%); Breast cancer ( C ) The immunohistochemical scores of the control group were ER (2+, 30%), PR (3+, 30%), and <t>HER2</t> (1+). The immunohistochemical scores of the DB group were ER (2+, 80%), PR (3+, 80%), and HER2 (1+) (×200)
Her2 Positive Metastatic Breast Cancer Cells, supplied by ATCC, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/her2 positive metastatic breast cancer cells/product/ATCC
Average 95 stars, based on 1 article reviews
her2 positive metastatic breast cancer cells - by Bioz Stars, 2026-05
95/100 stars
  Buy from Supplier
her2 neu  (Cell Marque)
86
Cell Marque her2 neu
Immunohistochemical (IHC) staining in control and marked groups. Lung cance ( A ) The immunohistochemical scores of the control group were TTF-1 (3+, 90%), Napsin A (3+, 80%), p53 (2+, 50%), Ki-67 (2+,70%), and PD-L1 (TPS < 1%). The immunohistochemical scores of the nano-TiO₂ group were TTF-1 (2+, 60%), Napsin A (3+, 90%), p53 (2+, 45%), Ki-67 (85%), and PD-L1 (TPS < 1%).TPS, tumor proportion score; Thyroid cancer ( B ) The immunohistochemical scores of the control group were Galectin-3 (3+, 90%), TPO (1+, 3%), CD56 (0), and BRAF V600E (3+, 80%). The immunohistochemical scores of the nano-TiO 2 group were Galectin-3 (2+, 70%), TPO (1+, 5%), CD56 (2+, 10%), and BRAF V600E (3+, 90%); Breast cancer ( C ) The immunohistochemical scores of the control group were ER (2+, 30%), PR (3+, 30%), and <t>HER2</t> (1+). The immunohistochemical scores of the DB group were ER (2+, 80%), PR (3+, 80%), and HER2 (1+) (×200)
Her2 Neu, supplied by Cell Marque, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/her2 neu/product/Cell Marque
Average 86 stars, based on 1 article reviews
her2 neu - by Bioz Stars, 2026-05
86/100 stars
  Buy from Supplier

Image Search Results


Immunohistochemical (IHC) staining in control and marked groups. Lung cance ( A ) The immunohistochemical scores of the control group were TTF-1 (3+, 90%), Napsin A (3+, 80%), p53 (2+, 50%), Ki-67 (2+,70%), and PD-L1 (TPS < 1%). The immunohistochemical scores of the nano-TiO₂ group were TTF-1 (2+, 60%), Napsin A (3+, 90%), p53 (2+, 45%), Ki-67 (85%), and PD-L1 (TPS < 1%).TPS, tumor proportion score; Thyroid cancer ( B ) The immunohistochemical scores of the control group were Galectin-3 (3+, 90%), TPO (1+, 3%), CD56 (0), and BRAF V600E (3+, 80%). The immunohistochemical scores of the nano-TiO 2 group were Galectin-3 (2+, 70%), TPO (1+, 5%), CD56 (2+, 10%), and BRAF V600E (3+, 90%); Breast cancer ( C ) The immunohistochemical scores of the control group were ER (2+, 30%), PR (3+, 30%), and HER2 (1+). The immunohistochemical scores of the DB group were ER (2+, 80%), PR (3+, 80%), and HER2 (1+) (×200)

Journal: Discover Nano

Article Title: Nano TiO2 and direct black marking system for precise localization in intraoperative pathological diagnosis of small tumors

doi: 10.1186/s11671-026-04631-5

Figure Lengend Snippet: Immunohistochemical (IHC) staining in control and marked groups. Lung cance ( A ) The immunohistochemical scores of the control group were TTF-1 (3+, 90%), Napsin A (3+, 80%), p53 (2+, 50%), Ki-67 (2+,70%), and PD-L1 (TPS < 1%). The immunohistochemical scores of the nano-TiO₂ group were TTF-1 (2+, 60%), Napsin A (3+, 90%), p53 (2+, 45%), Ki-67 (85%), and PD-L1 (TPS < 1%).TPS, tumor proportion score; Thyroid cancer ( B ) The immunohistochemical scores of the control group were Galectin-3 (3+, 90%), TPO (1+, 3%), CD56 (0), and BRAF V600E (3+, 80%). The immunohistochemical scores of the nano-TiO 2 group were Galectin-3 (2+, 70%), TPO (1+, 5%), CD56 (2+, 10%), and BRAF V600E (3+, 90%); Breast cancer ( C ) The immunohistochemical scores of the control group were ER (2+, 30%), PR (3+, 30%), and HER2 (1+). The immunohistochemical scores of the DB group were ER (2+, 80%), PR (3+, 80%), and HER2 (1+) (×200)

Article Snippet: The immunohistochemical scores of the nano-TiO 2 group were Galectin-3 (2+, 70%), TPO (1+, 5%), CD56 (2+, 10%), and BRAF V600E (3+, 90%); Breast cancer ( C ) The immunohistochemical scores of the control group were ER (2+, 30%), PR (3+, 30%), and HER2 (1+).

Techniques: Immunohistochemical staining, Immunohistochemistry, Control